No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bone Marrow Transplantation / adverse effects
-
Boronic Acids / therapeutic use
-
Bortezomib
-
Bulbar Palsy, Progressive / etiology*
-
Bulbar Palsy, Progressive / pathology
-
Combined Modality Therapy
-
Cranial Fossa, Posterior / pathology*
-
Cranial Nerve Diseases / etiology
-
Cyclosporine / adverse effects
-
Cyclosporine / therapeutic use
-
Dexamethasone / administration & dosage
-
Disease Progression
-
Doxorubicin / administration & dosage
-
Fatal Outcome
-
Female
-
Graft vs Host Disease / etiology
-
Humans
-
Immunocompromised Host
-
Immunoglobulin Light Chains / blood
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Magnetic Resonance Imaging
-
Methylprednisolone / adverse effects
-
Methylprednisolone / therapeutic use
-
Middle Aged
-
Multiple Myeloma / complications*
-
Multiple Myeloma / drug therapy
-
Multiple Myeloma / pathology
-
Multiple Myeloma / surgery
-
Myeloma Proteins / analysis
-
Pneumonia, Aspiration / etiology
-
Pyrazines / therapeutic use
-
Reflex, Abnormal
-
Transplantation, Homologous / adverse effects
-
Vincristine / administration & dosage
Substances
-
Boronic Acids
-
Immunoglobulin Light Chains
-
Immunosuppressive Agents
-
Myeloma Proteins
-
Pyrazines
-
Vincristine
-
Bortezomib
-
Dexamethasone
-
Doxorubicin
-
Cyclosporine
-
Methylprednisolone